Long‐Term Outcomes of Transcatheter Aortic Valve Replacement in Low‐Flow Low‐Gradient Aortic Stenosis: A Reconstructed Time‐to‐Event and Multivariate Meta‐Analysis

Journal of the American Heart Association, Volume 15, Issue 9 , May 5, 2026. BackgroundThere are uncertainties regarding long‐term outcomes of low‐flow, low‐gradient (LFLG) severe aortic stenosis (AS) following transcatheter aortic valve replacement (TAVR).

This study investigates long‐term outcomes of TAVR for high‐gradient (HG), classical LFLG, and paradoxical LFLG AS.MethodsWe systematically searched PubMed, Embase, Scopus, and Cochrane Library databases until January 2025 for studies comparing HG, classical LFLG, and paradoxical LFLG AS outcomes following TAVR. The primary outcome was all‐cause mortality, analyzed using reconstructed individual patient data meta‐analysis.

Secondary outcomes included cardiovascular mortality, heart failure hospitalization, acute kidney injury, bleeding events, stroke, myocardial infarction, permanent pacemaker implantation, and echocardiographic outcomes, analyzed using multivariate meta‐analysis.ResultsWe included 19 observational studies comprising 20 493 patients who underwent TAVR for severe AS. Time‐to‐event meta‐analysis indicated a higher risk of 5‐year all‐cause mortality in patients with classical and paradoxical LFLG AS compared with HG AS (hazard ratio [HR], 1.92 [95% CI, 1.62–2.27] and HR, 1.20 [95% CI, 1.07–1.34], respectively).